Drug-drug interaction study of repaglinide with regard to CYP2C8 and OATP1B1

Trial Profile

Drug-drug interaction study of repaglinide with regard to CYP2C8 and OATP1B1

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2015

At a glance

  • Drugs Repaglinide (Primary) ; Clopidogrel; Pioglitazone; Pitavastatin; Rifampicin; Trimethoprim
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Apr 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan.
    • 20 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top